Ansa Biotechnologies is a leading enzymatic DNA synthesis company developing a novel, enzyme-based technology to synthesize DNA. This technology aims to be faster, more accurate, and cleaner than existing methods, accelerating innovation in synthetic biology, medicine, agriculture, and industrial biotechnology.
- Category
- DNA Synthesis
- Stage
- Series B
- Employees
- 127
- HQ
- Emeryville, United States
- Founded
- 2018
- Funding
- $177M